Constitutional Challenges to the Compulsory HIV Testing of Prisoners and the Mandatory Segregation of HIV-Positive Prisoners

1993 ◽  
Vol 73 (3) ◽  
pp. 391-422 ◽  
Author(s):  
KENNETH C. HAAS

Intravenous drug use is both a common aspect of the pre-imprisonment lifestyles of many American prisoners and a leading risk factor for contracting HIV—the virus that causes AIDS. Moreover, incarcerated inmates frequently engage in behavior that can spread the disease, particularly homosexual activity and intravenous drug use. Correctional officials face increasing pressure to protect inmates and staff from HIV infection, and some have responded by implementing policies requiring all inmates to undergo HIV testing and by housing HIV-positive inmates in separate units. Screening and segregation policies, however, have been challenged on constitutional grounds by HIV-positive prisoners. This article examines the leading constitutional developments in this emerging area of law and finds that most courts so far have been inclined to reject constitutional challenges to mandatory testing and segregation policies. There are enough unsettled issues, however, to warrant expanded appellate review and eventual U.S. Supreme Court resolution of the key constitutional questions.

1993 ◽  
Vol 38 (6) ◽  
pp. 655-656
Author(s):  
Terri Gullickson

AIDS ◽  
1996 ◽  
Vol 10 (12) ◽  
pp. 1446-1447 ◽  
Author(s):  
J A Caylà ◽  
P García de Olalla ◽  
H Galdós-Tangüis ◽  
R Vidal ◽  
J Ll López-Colomés ◽  
...  

1997 ◽  
Vol 8 (4) ◽  
pp. 251-255 ◽  
Author(s):  
Nina Singh ◽  
Cheryl Squier ◽  
Carla Sivek ◽  
Marilyn M Wagener ◽  
Victor L Yu

We aim to assess the age-related differences in psychological stress and depression in patients with human immunodeficiency virus (HIV) infection. Prospective, longitudinal, observational study of patients with HIV followed at a university affiliated VA Medical Center. Fifty-six consecutive patients with HIV infection aged 19-68 were studied. Data on demographics, living arrangements, education, employment, income, social, religious, and community support, medical status, psychological stress, depression, and coping was assessed at baseline and every 6 months. Instruments for psychological testing included Beck Depression Inventory, Profile Mood Status (POMS) scale and ways of coping scale (inventory of coping with illness scale). Sixty-nine per cent (38/56) of the patients were older than 35 years of age. Older patients exhibited significantly greater emotional and psychological stress; the mean POMS score for older patients was 56.8 as compared to 21.5 for younger patients (P=0.004). Older patients had significantly greater depression (P=0.001), higher tension and anxiety (P=0.005), greater anger and hostility (P=0.03), greater confusion and bewilderment (P=0.01), and more fatigue (P=0.003) as compared with younger patients. Older patients were significantly more likely to have intravenous drug use as an HIV risk factor (P=0.02), less likely to be employed (P=0.005), and more likely to use non-traditional therapies (P=0). Intravenous drug use was an independent predictor of psychological stress in older patients. Patients with HIV, older than 35 years of age, are significantly more likely to suffer from depression and psychological stress; intravenous drug use was an independent predictor of stress. Interventions for the treatment of depression should be especially sought in this subgroup of patients with HIV.


QJM ◽  
1997 ◽  
Vol 90 (10) ◽  
pp. 617-629 ◽  
Author(s):  
R.P. Brettle ◽  
A. Chiswick ◽  
J. Bell ◽  
A. Busuttil ◽  
A. Wilson ◽  
...  

2013 ◽  
Vol 29 (1(Suppl)) ◽  
Author(s):  
Marjan Hashemipour ◽  
Zary Nokhodian ◽  
Majid Yaran ◽  
Behrooz Ataei ◽  
Katayoon Tayeri ◽  
...  

PEDIATRICS ◽  
1991 ◽  
Vol 88 (6) ◽  
pp. 1248-1256
Author(s):  
Marguerite M. Mayers ◽  
Katherine Davenny ◽  
Ellie E. Schoenbaum ◽  
Anat R. Feingold ◽  
Peter A. Selwyn ◽  
...  

A prospective study was conducted in the Bronx, New York, of 70 infants of human immunodeficiency virus (HIV)-infected (n = 33) and uninfected (n = 37) mothers who had a history of intravenous drug use or of intravenous drug-using sex partners. Infants were observed from birth to a median age of 23 months (range 3 to 54 months). HIV infection was confirmed in seven infants (21%) of seropositive mothers; six developed HIV disease, with symptoms observed in the first year. Of these, three died (3, 9, and 36 months) of HIV-related causes; 3 of 4 survivors were >25 months of age. HIV symptoms preceded or were concurrent with abnormalities in T-lymphocyte subsets; postneonatal polymerase chain reaction confirmed HIV infection in five infants with symptoms and one without symptoms. Among infants of seropositive mothers, seven without laboratory evidence of HIV (including polymerase chain reaction) had findings suggestive of HIV infection, including persistent generalized lymphadenopathy, hepatosplenomegaly, oral candidiasis, parotitis, and inverted T-lymphocyte ratios. These findings were not observed in infants of seronegative mothers. Although the presence of HIV proviral sequences was associated with HIV disease, the observation of indeterminate symptoms in at-risk infants indicates the importance of long-term clinical follow-up to exclude HIV infection. Disease manifestations in comparable infants of seronegative mothers are important for assessment of the impact of maternal drug use, development of specific clinical criteria for early diagnosis of HIV and eligibility for antiretroviral therapy.


Sign in / Sign up

Export Citation Format

Share Document